Trial Profile
A Multicenter, Contrasted Clinical Study on Efficacy and Safety of Recombinant Human Interferonα2b Spray in the Treatment of Hand-foot-and --mouth Disease in Kids
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Nov 2017
Price :
$35
*
At a glance
- Drugs Interferon alpha-2b (Primary) ; Ribavirin
- Indications Coxsackievirus infections
- Focus Therapeutic Use
- 02 Nov 2017 New trial record